Business
Gabriela Dieguez, FSA, MAAA, Amy W. Law, PharmD, Richard Lynen, MD, James Trussell, PhD, Bruce S. Pyenson, FSA, MAAA
A Call to Action to Address Burden of Unintended Pregnancies in Plans’ Benefit Design
Chakkarin Burudpakdee, PharmD, Anshul Shah, BS Pharm, MS, Vijay N Joish, PhD, Christine H. Divers, PhD, Avin Yaldo, PhD
Is It Time for Risk-Sharing Contracts In Specialty Pharmacy?
Paul S Chan, MD, MSc, Heidi C. Lew, PharmD, Toros Cagla PhD, Brian K. Solow, MD, FAAFP, Karen M. Stockl, PharmD, Josephine N. Tran, PharmD, MS
Real-World Consequences of the 2013 ACC/AHA Cholesterol Guidelines for the Prevention of Cardiovascular Disease
Rashad Carlton, PharmD, MSPH, Cathryn A. Carroll, PhD, Orsolya Lunacsek, PhD, Timothy S. Regan, BPharm, RPh, CPh
Out-of-Pocket Cost of Therapy Can Affect Patients’ Excessive Sleepiness and Daytime Functioning
Drug Shortages Are Costly to Patients and to Payers
The Hidden Market of Counterfeit Drugs a Concern for All Stakeholders
The Clinical Toll of Nonvalvular Atrial Fibrillation Poses Significant Economic Burden
Michael S. Broder, MD, MSHS, Claudio Faria, PharmD, MPH, Annette Powers, PharmD, MBA, Jehangeer Sunderji, MD, Dasha Cherepanov, PhD
The Value of Pharmaceuticals in the Prevention and Treatment of CINV
Disruptive Innovation, Uncertain Value, and Economic Modeling in Oncology
Christopher M. Blanchette, PhD, MBA, Nicholas J. Gross, MD, PhD, Pablo Altman, MD, MBA, F. Randy Vogenberg, PhD, FASHP
Chronic Obstructive Pulmonary Disease Remains a Growing Population Health Concern